G Medical Innovations Holdings Limited - Warrants (30/06/2025) Profit Margin

G Medical Innovations Holdings Limited - Warrants (30/06/2025) posts a profit margin of 157.6% as of December 2021. That compares with -941.84% in the prior-year period — up 116.7% year over year. That is above the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s profit margin was -941.84%. The latest reading is 157.6% — a 116.7% year-over-year increase (period ending December 2021). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s 157.6% is higher that level. That is roughly 1034.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 157.6% as of December 2021; use YoY and peer views to separate noise from signal.

Context for GMVDW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s other metric pages and overview cover the third.